Prostate Cancer Research - New Prostate Cancer Study

Prostate Cancer Research is conducted by scientists and doctors all across the world. It is of utmost important in helping to curb the terrible disease.

Prostate Cancer Research – University of California Los Angeles Campus

A prostate cancer study performed by a research team at the University of California ’s Los Angeles campus showed a possible connection between drinking pomegranate juice and slowing down the growth of prostate cancer. The team conducted a prostate cancer research study in which subjects were asked to drink an 8-ounce glass of pomegranate juice once daily. The prostate cancer study was conducted over three years and was published in Clinical Cancer Research. Led by Dr Allan Pantuck, the study included 50 test subjects who had undergone prostate cancer surgery or prostate cancer radiation treatment to treat their prostate cancer.

The results of the Prostate Cancer Research Study showed that the consumption of the juice contributed to stabilizing levels of Protein-Specific-Antigens, which are found in increasing numbers in the body when someone has a case of prostate cancer. The stabilized PSA levels lasted nearly four times as long as usual when the subjects drank pomegranate juice. This more balanced level may be a factor to a slowing of the growth of prostate cancer, which is of extreme importance to those diagnosed with the disease. Once a prostate cancer tumor has grown large enough to extend to other parts of the body, the mortality rate connected with the disease is known to increase by a large amount. For that reason, any method of slowing down the disease is of utmost importance.

Prostate Cancer Study: University of California San Francisco Campus

Another prostate caner study conducted by the University of California , this time at their San Francisco campus , highlighted the qualities of a prostate cancer vaccine. The results of the prostate cancer study state that men with an advanced, untreatable case of prostate cancer who are given a cancer vaccine survive a longer life than those who were given a placebo. On an average, those who received the vaccine lived four and a half months longer than those who received the placebo. The vaccine was well-tolerated amongst the test subjects, with only little side effects being reported that included fever and chills.

The name of the vaccine used in the prostate cancer research study is sipuleucel-T, which was invented by the Dendreon Corporation. The vaccine aided the patient’s endurance because of the fact that it was designed to help to stimulate the T-cells’ immunity to damage from prostatic acid phosphatase, which is found almost exclusively in prostate cancers.127 patients contributed in the prostate caner research study, and the results give hope for those who have an advanced form of the lethal disease. When it comes to using immunotherapy, it’s the first study that has ever shown any merit to help extend the life span when it comes to treating prostate cancer.

In the fight against prostate caner, these prostate cancer research studies represent a few small steps. More and more research is being conducted about this deadly disease, and progress cannot be made devoid of proper funding. If you wish to donate to prostate cancer research, many trustworthy charities can be found online which could really use your backing.